Industry: GDP Guidelines Would Increase EU Costs
Big pharmaceutical and logistics companies say draft good distribution practice (GDP) guidelines from the European Commission would "significantly increase the cost of medicinal product supply chains," according to a published report by Outsourcing Pharma.
The statement is attributed UPS, a worldwide shipper, that is concerned about the classification of any period when products are held at a site for longer than 24 hours as a regulated activity.
The report states a scientist at Merck Sharp & Dohme called the requirement "excessive and not realistic." A representative from Bristol-Myers is worried that carries will refuse to ship pharmaceutical products to do the demands of the draft GDP guidelines.
Read more:
Outsourcing Pharma: GDP Guidelines Would Increase EU Supply Chain Costs; Industry